Table 1 . The hematological characteristics of the study population in baseline, on HAART and after vitamins treatment .
| Studied factors | Male status | p | Female status | p | Overall status | p |
| Hb (g/dL) | ||||||
| Baseline Mean ± SD | 12.2±2.5 | 11.6±2.7 | 11.9±2.6 | |||
| On HAART Mean ± SD | 12.6±2.7 | p= 0.2783a | 12.1±1.7 | p= 0.1187 | 12.3±2.6 | p= 0.2780 |
| Vitamins Mean ± SD | 12.9±2.1 | p= 0.3815 b | 12.2±1.5 | p= 0.6596 | 12.5±1.8 | p= 0.5278 |
| HCT (%) | ||||||
| Baseline Mean ± SD | 36.4±7.1 | 34±4.8 | 35.1±6.1 | |||
| On HAART Mean ± SD | 39.3±5.8 | p= 0.0018 | 36.4±5 | p= 0.0007 | 37.8±5.6 | p= 0.0013 |
| Vitamins Mean ± SD | 39.3±5.5 | p= 1.0000 | 37.9±4 | p= 0.0201 | 38.6±4.8 | p= 0.2794 |
| MCV (fL) | ||||||
| Baseline Mean ± SD | 81±16.2 | 77.5±8.6 | 79.1±12.7 | |||
| On HAART Mean ± SD | 104.2± 20.5 | p< 0.0001 | 99.6± 14 | p< 0.0001 | 101.7± 17.4 | p< 0.0001 |
| Vitamins Mean ± SD | 98.4±14.7 | p= 0.0225 | 95.6±13.3 | p= 0.0396 | 96.9±13.9 | p= 0.0323 |
| MCH (Pg) | ||||||
| Baseline Mean ± SD | 29±5.5 | 26.3±4.2 | 27.6±5 | |||
| On HAART Mean ± SD | 33.2± 5.4 | p< 0.0001 | 31.7± 5.2 | p< 0.0001 | 32.4± 5.3 | p< 0.0001 |
| Vitamins Mean ± SD | 32.3±5.8 | p= 0.2575 | 31.2±5.2 | p= 0.4974 | 31.7±5.5 | p= 0.3605 |
| MCHC (g/dL) | ||||||
| Baseline Mean ± SD | 33±3.8 | 32.1±3.8 | 32.5±3.9 | |||
| On HAART Mean ± SD | 32.2±5.4 | p= 0.2271 | 33±2.8 | p= 0.0580 | 32.6±4.2 | p= 0.8617 |
| Vitamins Mean ± SD | 33.2±7.4 | p= 0.2763 | 31.8±4 | p= 0.0148 | 32.4±5.8 | p= 0.7803 |
| RDWCV (%) | ||||||
| Baseline Mean ± SD | 13.6±1.4 | 15.3±8.3 | 14.5±6.2 | |||
| On HAART Mean ± SD | 14.1 ±2.2 | p= 0.0566 | 13.7 ±1.8 | p= 0.0610 | 13.9 ±2 | p= 0.3582 |
| Vitamins Mean ± SD | 13.9±2.5 | p= 0.5488 | 13.5±1.3 | p= 0.3688 | 13.7±2 | p= 0.4803 |
| PLT (x10 3 /µL) | ||||||
| Baseline Mean ± SD | 185.9±93.8 | 253.2±130.1 | 222.2±119.2 | |||
| On HAART Mean ± SD | 194.9±78.8 | p= 0.4634 | 257.8±87.4 | p= 0.7695 | 228.6±88.9 | p= 0.6674 |
| Vitamins Mean ± SD | 205.6±84.6 | p= 0.3558 | 291.9±103.6 | p= 0.0127 | 252.2±104.2 | p= 0.0864 |
| RBC (x10 6 /µL) | ||||||
| Baseline Mean ± SD | 5±4.5 | 4.3±0.9 | 4.6±3.1 | |||
| On HAART Mean ± SD | 4±0.9 | p= 0.0305 | 3.7±0.7 | p< 0.0001 | 3.9±0.8 | p= 0.0300 |
| Vitamins Mean ± SD | 6.4±3.8 | p< 0.0001 | 5.6±5.2 | p= 0.0004 | 6±4.6 | p< 0.0001 |
| WBC (x10 3 /µL) | ||||||
| Baseline Mean ± SD | 5±2.2 | 4.8±2.1 | 4.9±2.1 | |||
| On HAART Mean ± SD | 5.2±2 | p= 0.5019 | 4.6±1.7 | p= 0.4600 | 4.9±1.9 | p= 1.0000 |
| Vitamins Mean ± SD | 4±2.3 | p= 0.0001 | 4.7±1.8 | p= 0.6867 | 4.3±2.1 | p= 0.0354 |
| TLC (x10 3 /µL) | ||||||
| Baseline Mean ± SD | 1.7±1.1 | 1.5±0.7 | 1.6±0.9 | |||
| On HAART Mean ± SD | 2.1±1 | p= 0.0077 | 1.7±0.8 | p= 0.0614 | 1.9±0.9 | p= 0.0194 |
| Vitamins Mean ± SD | 2.4±1.4 | p= 0.0828 | 2±1 | p= 0.0201 | 2.2±1.2 | p= 0.0469 |
a: Baseline status compared with On HAART status, b: On HAART status compared with vitamins status